Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: The Everolimus-Transplant Exit Strategy Trial (E-TEST) [Phase 3]
Phase 3 trial (E-TEST) investigating everolimus in kidney failure; terminated with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 [Phase 4]
A Phase 4 clinical trial update examining the effect of a Vitamin D supplement on osteoprotegerin expression and disease progression in pati…
-
FDA approval · 2015-06-05FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for furosemide from Marlex Pharmaceuticals, Inc., updating the product label.
-
FDA approval · 2015-06-05FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for DIANEAL PD-2 WITH DEXTROSE, a peritoneal dialysis solution, under Vantive US Healthcare LLC.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) [Phase 3]
The SWEEP Phase 3 trial evaluating HX575 for anemia associated with chronic kidney disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients [Phase 4]
Phase 4 clinical trial comparing platelet resistance with ticagrelor versus standard-dose clopidogrel in patients with Acute Coronary Syndro…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Exercise Intolerance in Renal Failure [Phase 2]
A Phase 2 clinical trial by Emory University on exercise intolerance in chronic kidney disease has completed and posted results.
-
FDA approval · 2015-05-27FDA Approved: PARICALCITOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for PARICALCITOL from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Evaluation of Colecalciferol Substitution in Dialysis Patients [NA]
Completed clinical trial evaluating colecalciferol substitution in dialysis patients with chronic kidney disease and secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Safety and Tolerability Study of MCI-196 [Phase 3]
Phase 3 safety and tolerability study of MCI-196 in chronic kidney disease patients, including those not on dialysis and paediatric populati…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Dose-finding Study of MCI-196 [Phase 3]
Phase 3 dose-finding study of MCI-196 sponsored by Tanabe Pharma has been terminated. The trial investigated MCI-196 in chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Long-term Extension Study of MCI-196 [Phase 3]
A terminated Phase 3 long-term extension study of MCI-196 in chronic kidney disease patients; the trial status has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Behavioral Intervention and Adherence in Dialysis [Phase 2]
Phase 2 clinical trial update evaluating a behavioral intervention to improve adherence in dialysis patients with chronic kidney disease. Th…
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant [NA]
The clinical trial NCT01619449 evaluating continuous renal replacement therapy in the setting of orthotopic liver transplantation has been w…
-
CLINICAL_TRIALS research · 2015-05-25Clinical Trial Update: Pharmaceutical Care in Ambulatory Hemodialysis Patients [NA]
This clinical trial update from Hospital Moinhos de Vento concerns pharmaceutical care and medication adherence for ambulatory patients on h…
-
FDA approval · 2015-05-22FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, expanding the regulatory approval for the product.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients [NA]
A completed clinical trial evaluated the renal-protective effects of a restricted protein diet with α-keto acids in CAPD patients.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Renal Function in PD Patients [NA]
Completed study assessing whether α-keto acid supplementation with a low-protein diet preserves renal function in patients on peritoneal dia…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Sleep Disorders in Pediatric Dialysis
A completed clinical trial investigating sleep disorders in pediatric patients with chronic kidney disease undergoing dialysis.
-
CLINICAL_TRIALS research · 2015-05-22Clinical Trial Update: Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 4]
Phase 4 clinical trial update investigating opioids in patients with chronic kidney disease undergoing hemodialysis. The current study statu…
-
CLINICAL_TRIALS research · 2015-05-21Clinical Trial Update: Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)
Clinical trial update focusing on malnutrition, diet, and racial disparities in chronic kidney disease (CKD).
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients [Phase 3]
A Phase 3 clinical trial evaluating anti-inflammatory and anti-oxidative nutrition in dialysis patients has completed.
-
CLINICAL_TRIALS withdrawal · 2015-05-21Clinical Trial Update: Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients [Phase 3]
A Phase 3 trial examining diuretic therapy to manage fluid status and preserve residual renal function in peritoneal dialysis patients was w…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients [NA]
Completed clinical trial evaluating renal protective effects of a Renin-Angiotensin System (RAS) inhibitor in peritoneal dialysis patients.
-
FDA approval · 2015-05-18FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for Ferric Citrate, approving a generic version of the iron-based ph…